Epidemiology of CKD in Children

Similar documents
Name of the study: INDIAN PEDIATRIC CHRONIC KIDNEY DISEASE REGISTRY. Dr Arvind Bagga, All India Institute of Medical Sciences, New Delhi

Maolynne Miller Paediatric Nephrologist UHWI Jamaica Kidney Kids Foundation/ International Paediatric Nephrology Association 1st Jamaican Paediatric

Chapter 8: ESRD Among Children, Adolescents, and Young Adults

ESRD Dialysis Prevalence - One Year Statistics

Chapter 7: ESRD among Children, Adolescents, and Young Adults

USRDS UNITED STATES RENAL DATA SYSTEM

Urinary tract infections in children with CAKUT and introduction of the PREDICT trial Giovanni Montini, Bologna, Italy.

Is antibiotic prophylaxis of any use in nephro-urology? Giovanni Montini Pediatric Nephrology and Dialysis Unit University of Milan Italy

3/5/18. Background. Registry Reports. Dialysis Registry Update and Future Directions

Case Report 17-Year-Old Boy with Renal Failure and the Highest Reported Creatinine in Pediatric Literature

Epidemiology of kidney diseases in children

2015 Children's Mercy Hospitals and Clinics. All Rights Reserved.

CHAPTER 2 PRIMARY GLOMERULONEPHRITIS

Thanks to our Speaker!

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT. J. H. Helderman,MD,FACP,FAST

Journal of Nephropathology

Chapter 15: Report of the Paediatric Renal Registry 1999

Chapter 1. Incidence of End Stage Kidney Disease. Contents:

CKD FOR INTERNISTS. Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College

NAPRTCS Annual Transplant Report

Chronic kidney disease in children as seen in a tertiary hospital in Enugu, South-East, Nigeria

NAPRTCS Annual Report

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

NAPRTCS Annual Transplant Report

Update on HIV-Related Kidney Diseases. Agenda

CHAPTER 2. Primary Glomerulonephritis

Progress in Pediatric Kidney Transplantation

SCOTTISH REAL BIOPSY REGISTRY: SURVEY OF NATIVE KIDNEY BIOPSY IN SCOTLAND 2015

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

Chronic kidney disease in children: the global perspective

NAPRTCS Annual Report

Appendix G Coding: Ethnicity, EDTA Primary Renal Diagnoses, EDTA Causes of Death and Treatment Timeline Modality Codes

Egfr non african american vs african american

Special Challenges and Co-Morbidities

Kidney Disease Profile of Syrian Refugee Children

KEEP 2.0 Annual Data Report Chapter Five

A New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta

North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) 2005 Annual Report. Renal Transplantation. Chronic Renal Insufficiency

Clinical pathological correlations in AKI

NAPRTCS Annual Report

CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN 2007

CHAPTER 3 SECONDARY GLOMERULONEPHRITIS

Chronic Kidney Disease

A. Zurowska has documented that she has no relevant financial relationships to disclose or conflict of interest to resolve.

Elevated Serum Creatinine, a simplified approach

The evidence base for interventions to slow the progression of chronic kidney disease: Medical interventions. Jonathan Evans Paediatric Nephrologist

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Case Studies: Renal and Urologic Impairments Workshop

Chapter 5 PAEDIATRIC RENAL REPLACEMENT THERAPY. Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Wan Jazilah Wan Ismail Yap Yok Chin

Renal Disease. Please refer to the assignment page Three online modules TBLs

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

A one-center experience with pediatric percutaneous renal biopsy and histopathology in Ankara, Turkey

What are the Challenges and Needs of Industry?

CHAPTER 3. Secondary Glomerulonephritis

Chapter IV. Incidence and Causes of Treated ESRD. Methods

THE KIDNEY AND SLE LUPUS NEPHRITIS

Clots and Foamy Urine: Thrombotic Complications of Nephrotic Syndrome. Prayus Tailor, MD October 5, 2013 Renal and Hypertension Symposium

Renal survival analysis of CAKUT and outcomes in chronic kidney disease.

RENINE year report 2016

Renal Diseases in Children Attending Pediatric Nephrology Centers of Dhaka City

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

Introduction. 1. Introduction

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT

Atypical IgA Nephropathy

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Approach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

16.1 Risk of UTI recurrence in children

Options in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

Prevalence of recurrent urinary tract infection in children with congenital anomalies of the kidney and urinary tract (CAKUT)

Keywords: children; diagnosis; etiology; hematuria; proteinuria. Introduction. Methods. Protocol. Eligibility

Urology in the Iranian Biomedical Journals

Professor Suetonia Palmer

Dialysis Mortality Regional Clinical Audit Report 2011

Chapter IX. Pediatric End Stage Renal Disease. Incidence of Reported Pediatric ESRD

Classification of CKD by Diagnosis

Creatinine & egfr A Clinical Perspective. Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC

C1q nephropathy the Diverse Disease

Identifying and Managing Chronic Kidney Disease: A Practical Approach

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

New Treatments for ADPKD how close are we?

10/25/2013. Tamara Hill, RN, BSN, MSN, CPNP-AC Division of Pediatric Nephrology University of Maryland Medical Center. Guideline KDOQI 2002

2014 /2018 ERA-EDTA PRD Code ERA-EDTA PRD code 1996 ERA-EDTA. SNOMED CT concept identifier Convert ERA-EDTA Primary Renal Diagnosis (PRD) Term

Jadranka Buturović-Ponikvar Department of Nephrology, University Medical Center, Ljubljana, Slovenia

Nephrotic Syndrome NS

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. HIV and the Kidney. Leah Haseley, MD. Presentation prepared by: LH NW AETC ECHO June 2012

Out of date SUGGESTIONS FOR CLINICAL CARE (Suggestions are based on level III and IV evidence)

Nephrology referral - Does my patient need it? Disclosure

Ashberyh CHAPTER. John

Practice Patterns and Outcomes of ACTHar use in Children with Nephrotic Syndrome

CKD Prevention Program Protocol

RENINE Annual Report 2015

Mignon McCulloch. Associate Professor Paediatric Nephrology/Critical Care Red Cross Children s Hospital (RXH) University of Cape Town

Building a clinical service for children with CKD in a developing country

ERA-EDTA ERA-EDTA Primary Renal Diagnosis (PRD) Term ERA-EDTA PRD classification SNOMED CT PRD Code 1/1/2015

Acute kidney injury definition, causes and pathophysiology. Financial Disclosure. Some History Trivia. Key Points. What is AKI

UK Renal Registry 20th Annual Report: Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population in 2016

Difference in practical dialysis therapy between East Asia and US/EU

Transcription:

Epidemiology of CKD in Children Ali Düzova, M.D. Hacettepe University Faculty of Medicine Pediatric Nephrology and Rheumatology Unit Ankara CKD Course 03 June 2011, İstanbul

Aim & Plan Causes of CKD in children Incidence & prevalence & risks for progression Plan 1990-2000 ItalKid Project ESPN Registry, NAPRTCS 2008 Annual reports Data from Turkey

K/DOQI stages of CKD Stage Description GFR (ml/min/1.73 m 2 ) I Kidney damage with normal or 90 increased GFR II Kidney damage with mild 60-89 decrease in GFR III Moderate decrease in GFR 30-59 IV Severe decrease in GFR 15-29 V Kidney failure <15 (or dialysis) Am J Kidney Dis 2002;39:S1 266.

Year of publication Country Period Study design Definition N M/F 1995 Turkey 1979-1993 Single center GFR <50 459 1.2 1997 Sweden 1986-994 Nationwide GFR <30 118 1.6 1999 Chile 1996 Nationwide GFR <30 227 1.0 1999 India NA-1 year Single center Cre > 2 mg/dl 48 2.2 2001 Iran 1991-1999 Single center GFR <30 166 1.3 2002 Japan 1998 Nationwide ESRD 105 1.9 2003 Nigeria 1985-2000 Single center GFR <30 45 1.6

Primary renal diseases in children; Sweden 1986-1994 35 30 CRF (< 30 ml/min) TRF (RRT) 25 20 15 10 5 0 Renal Obstructive Hereditary Glomerulopathies Vascular Other hypo/dysplasia uropathies disorders nephropathies Esbjörner et al. Pediatr Nephrol 1997; 11: 438-442.

Country n Incidence Prevalence Sweden (1986-1994) 118 7.7 25.0 Chile (1996) 227 5.7 42.5 Iran (1991-1999) 166 NA NA 30 25 20 Sweden Chile Iran 15 10 5 0 Renal Obstructive Hereditary Glomerulopathies Vascular VUR Other hypo/dysplasia uropathies disorders nephropathies Esbjörner et al. Pediatr Nephrol 1997; 11: 438-442. Lagomarsimo et al. Pediatr Nephrol 1999; 13: 288-291. Madani et al. Pediatr Nephrol 2001; 16: 140-144.

ItalKid Project Population based registry in 1990 Covered the entire country, 16.8 million children Inclusion criteria Creatinine clearance of 75 ml/min/1.73 m 2 for children < 1 year: Serum Cre > mean scr + 3 SD; Age younger than 20 years at the time of registration

ItalKid Project In 10 years, 1.197 pts. have been registered. M/F: 2.03 for the population as a whole 1.72 when the pts. with PUV were excluded. The mean age at registration: 6.9 5.4 years The mean Ccr at registration: 41.7 20.5 ml/min/ 1.73 m 2 The mean incidence (1995 2000): 12.1 cases pmarp (8.8 13.9). The point prevalence (January 1, 2001) 74.7 cases pmarp

The incidence of RRT was 7.3/year/100 patients The risk of developing ESRD by the age of 20 years was 68%

ESPN 2008 Report Total population: 628 million Children (0-14 years): 98 million (15.6%) Patients accepted for RRT Incidence 5.2 pmarp (0-24.5) Prevalence 28.6 pmarp (3.2-72.6)

ESPN 2008 Report 0 10 20 30 40 Glomerulonephritis CAKUT Cystic KD Hereditary Ishemic HUS Metabolic Vasculitis Pyelonephritis Miscellaneous 7,2 2,2 5,8 3,4 2,8 1,2 7 7,4 11,8 15,2 35,3 Unknown

NAPRTCS 2008 (n: 7036) (1994; GFR < 75; Canada, Mexico, Costa Rica, USA) (%) 16 14 12 10 8 6 4 2 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18- Age (years) 20

NAPRTCS 2008 Structural Prune belly, reflux nephropathy and aplasia/hypoplasia/displasias Glomerulonephritis Chronic GN, idiopathic crescentic GN MPGN, MGN, SLE, HSP, IgAN Wegener s granulomatosis FSGS Other

NAPRTCS 2008 (n: 7026) 100% 80% 60% 40% 20% 73 64,2 58,2 16,2 16,5 38,7 55,9 Other FSGS GN Structural 0% 0-1 year 2-5 years 6-12 years > 12 years Total

NAPRTCS 2008 100% 80% 60% 18,5 Other 40% 20% 59,3 49,5 51,6 51 55,9 FSGS GN Structural 0% White Black Hispanic Other race Total

Causes of CKD 100 80 EDTA-1976 60 40 EDTA-2004 USRDS-2005 Italkid 20 BAPN 0 Unknown CAKUT Other familial SUM NAPRTCS &congenital Adapted from: Neild GH. Pediatr Nephrol 2009; 24: 1913-1919.

Etiology of chronic renal failure in Turkey Study period: 1979-1993 GFR < 50 459 children M/F: 1.23 (254/205) 0 10 20 30 40 Reflux nephropathy Glomerular diseases Hereditary Amyloidosis Urinary stones Other 8 11,4 10,6 15,4 22,2 32,4 Sirin A et al. Pediatr Nephrol 1995; 9: 549-552.

Turkish Society for Pediatric Nephrology-CKD Working Group 29 pediatric nephrology centers in Turkey egfr 75 ml/min per 1.73 m 2 < 19 years, diagnosed in 2005 282 patients M/F 1.29 (159/123) mean age 8.05 ± 5.25 years

Age distribution of patients at diagnosis (%) 35 30 25 20 15 10 5 0 29 31 27,2 12,8 0-4 yrs 5-9 yrs 10-14 yrs 15-18 yrs Bek et al. Turkish SPN CKDWG. Pediatr Nephrol 2009; 24:797-806.

CKD stages of the patients at diagnosis (%) 35 30 25 20 15 10 5 0 32,5 29,8 25,8 11,9 II III IV V Bek et al. Turkish SPN CKDWG. Pediatr Nephrol 2009; 24:797-806.

Causes of CKD (%) 0 10 20 30 40 50 Urological problems Hypoplasia; dysplasia, aplasia Cystic d. Hereditary metabolic Primary GN Sec. GN 4,9 4,6 7 12,6 11,4 44,3 Bek et al. Turkish SPN CKDWG. Pediatr Nephrol 2009; 24:797-806.

70 60 50 40 30 20 NAPRTCS Italkid Turkey 10 0 Structural GN FSGS Other

Summary Leading causes: CAKUT, Other congenital and familial diseases. Factors affecting the pattern Race, ethnicity, environment, wealth, age, time Preventable, curable in certain cases Measures to slow down progression